595 related articles for article (PubMed ID: 32081200)
21. Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules.
Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
Front Immunol; 2020; 11():618231. PubMed ID: 33603747
[TBL] [Abstract][Full Text] [Related]
22. Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases.
Zhang X; Xu A; Lv J; Zhang Q; Ran Y; Wei C; Wu J
Eur J Med Chem; 2020 Jan; 185():111822. PubMed ID: 31699536
[TBL] [Abstract][Full Text] [Related]
23. The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia.
Urwanisch L; Luciano M; Horejs-Hoeck J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525345
[TBL] [Abstract][Full Text] [Related]
24. Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes.
Gong T; Yang Y; Jin T; Jiang W; Zhou R
Trends Immunol; 2018 May; 39(5):393-406. PubMed ID: 29452983
[TBL] [Abstract][Full Text] [Related]
25. Reviewing the importance of TLR-NLRP3-pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors.
Kinra M; Nampoothiri M; Arora D; Mudgal J
Scand J Immunol; 2022 Feb; 95(2):e13124. PubMed ID: 34861056
[TBL] [Abstract][Full Text] [Related]
26. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases.
Abderrazak A; Syrovets T; Couchie D; El Hadri K; Friguet B; Simmet T; Rouis M
Redox Biol; 2015; 4():296-307. PubMed ID: 25625584
[TBL] [Abstract][Full Text] [Related]
27. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
Takahashi M
J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
[TBL] [Abstract][Full Text] [Related]
28. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
29. Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome.
Shim DW; Lee KH
Front Immunol; 2018; 9():1054. PubMed ID: 29868015
[TBL] [Abstract][Full Text] [Related]
30. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
Martínez GJ; Celermajer DS; Patel S
Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of IRE1α RNase activity reduces NLRP3 inflammasome assembly and processing of pro-IL1β.
Talty A; Deegan S; Ljujic M; Mnich K; Naicker SD; Quandt D; Zeng Q; Patterson JB; Gorman AM; Griffin MD; Samali A; Logue SE
Cell Death Dis; 2019 Aug; 10(9):622. PubMed ID: 31417078
[TBL] [Abstract][Full Text] [Related]
32. NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma.
McKee CM; Coll RC
J Leukoc Biol; 2020 Sep; 108(3):937-952. PubMed ID: 32745339
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors.
Yang Y; Wang H; Kouadir M; Song H; Shi F
Cell Death Dis; 2019 Feb; 10(2):128. PubMed ID: 30755589
[TBL] [Abstract][Full Text] [Related]
34. Regulation of NLRP3 Inflammasome by Phosphorylation.
Song N; Li T
Front Immunol; 2018; 9():2305. PubMed ID: 30349539
[TBL] [Abstract][Full Text] [Related]
35. Interplay Between NLRP3 Inflammasome and Autophagy.
Biasizzo M; Kopitar-Jerala N
Front Immunol; 2020; 11():591803. PubMed ID: 33163006
[TBL] [Abstract][Full Text] [Related]
36. NLRP3 Is Involved in Ischemia/Reperfusion Injury.
Guo Z; Yu S; Chen X; Ye R; Zhu W; Liu X
CNS Neurol Disord Drug Targets; 2016; 15(6):699-712. PubMed ID: 26996163
[TBL] [Abstract][Full Text] [Related]
37. NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases.
Zhang Y; Yang W; Li W; Zhao Y
Front Immunol; 2021; 12():732933. PubMed ID: 34707607
[TBL] [Abstract][Full Text] [Related]
38. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.
Grebe A; Hoss F; Latz E
Circ Res; 2018 Jun; 122(12):1722-1740. PubMed ID: 29880500
[TBL] [Abstract][Full Text] [Related]
39. The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers.
Gouravani M; Khalili N; Razi S; Keshavarz-Fathi M; Khalili N; Rezaei N
Expert Rev Clin Immunol; 2020 Feb; 16(2):175-187. PubMed ID: 31928260
[No Abstract] [Full Text] [Related]
40. GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics.
Tang T; Gong T; Jiang W; Zhou R
Trends Pharmacol Sci; 2018 Sep; 39(9):798-811. PubMed ID: 30054020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
